BRIEF-Neurocrine and Bial reports exclusive North American licensing agreement for opicapone By: Reuters: Company News February 09, 2017 at 16:11 PM EST * Neurocrine and Bial announce exclusive North American licensing agreement for opicapone Read More >> Related Stocks: Neurocrine Bioscienc